Joseph Edward Tucker
Chief Executive Officer at Enveric Biosciences Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Enveric Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lakewood-Amedex Biotherapeutics Inc. September 22, 202676.9%
-
Enveric Biosciences Inc. May 28, 202491.2%
-
Enveric Biosciences Inc. November 2, 202394.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Enveric Biosciences Inc. | Grant or award | +201,124 | — | — |
| Dec 23, 2025 | Enveric Biosciences Inc. | Grant or award | +60,296 | — | — |
| May 8, 2025 | Enveric Biosciences Inc. | Grant or award | +98,866 | — | — |
| Oct 9, 2024 | Enveric Biosciences Inc. | Grant or award | +161,633 | — | — |
| Feb 22, 2024 | Enveric Biosciences Inc. | Grant or award | +100,000 | — | — |
| Jan 25, 2023 | Enveric Biosciences Inc. | Grant or award | +44,000 | — | — |
| Oct 13, 2021 | Enveric Biosciences Inc. | Grant or award | +1,374 | — | — |
| Oct 13, 2021 | Enveric Biosciences Inc. | Grant or award | +15,000 | — | — |
Questions about Joseph Edward Tucker
What boards is Joseph Edward Tucker on?
Joseph Edward Tucker sits on the boards of Enveric Biosciences Inc. and Lakewood-Amedex Biotherapeutics Inc.
What company is Joseph Edward Tucker the CEO of?
Joseph Edward Tucker is Chief Executive Officer of Enveric Biosciences Inc.
How long has Joseph Edward Tucker served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.